English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/230353
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Coenzyme Q10 Treatment Monitoring in Different Human Biological Samples

AuthorsParedes-Fuentes, Abraham J.; Montero, Raquel; Codina, Anna; Jou, Cristina; Fernandez, Guerau; Maynou, Joan; Santos-Ocaña, Carlos ; Riera, Joan; Navas, Plácido ; Drobnic, Franchek; Artuch, Rafael
KeywordsCoenzyme Q10
Antioxidants
Supplementation
Treatment monitoring
Skeletal muscle
Urine
Platelets
Blood mononuclear cells
Plasma
Issue Date2020
PublisherMultidisciplinary Digital Publishing Institute
CitationAntioxidants 9(10): 979 (2020)
AbstractCoenzyme Q10 (CoQ) treatment monitoring is a matter of debate since CoQ distribution from plasma to blood cells and tissues is not fully understood. We aimed to analyze the CoQ levels in a wide set of human biological samples (plasma, blood mononuclear cells (BMCs), platelets, urinary cells, and skeletal muscle) from a group of 11 healthy male runners before and after CoQ supplementation. The CoQ content in the different samples was analyzed by HPLC coupled to electrochemical detection. No significant differences were observed in the CoQ levels measured in the BMCs, platelets, and urine after the one-month treatment period. Plasma CoQ (expressed in absolute values and values relative to total cholesterol) significantly increased after CoQ supplementation (p = 0.003 in both cases), and the increase in CoQ in muscle approached significance (p = 0.074). CoQ levels were increased in the plasma of all supplemented subjects, and muscle CoQ levels were increased in 8 out of 10 supplemented subjects. In conclusion, the analysis of CoQ in plasma samples seems to be the best surrogate biomarker for CoQ treatment monitoring. Moreover, oral CoQ administration was effective for increasing muscle CoQ concentrations in most subjects.
Description© 2020 by the authors.
Publisher version (URL)http://dx.doi.org/10.3390/antiox9100979
URIhttp://hdl.handle.net/10261/230353
DOIhttp://dx.doi.org/10.3390/antiox9100979
E-ISSN2076-3921
Appears in Collections:(CABD) Artículos
Files in This Item:
File Description SizeFormat 
Coenzyme_Paredes_PV_Art2020.pdf1,38 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.